Choroidal Neovascularization Following Implantation of Verisyse™ Iris-Supported Phakic Intraocular Lens in a Pregnant Myopic Patient

Brent S Betts, Thomas J Oberg, Maylon Hsu, Majid Moshirfar*
John A. Moran Eye Center, 65 Mario Capecchi Drive, Salt Lake City, Utah 84132, USA

Article Metrics

CrossRef Citations:
Total Statistics:

Full-Text HTML Views: 2511
Abstract HTML Views: 1960
PDF Downloads: 623
Total Views/Downloads: 5094
Unique Statistics:

Full-Text HTML Views: 1218
Abstract HTML Views: 1191
PDF Downloads: 430
Total Views/Downloads: 2839

Creative Commons License
© Betts et al.; Licensee Bentham Open.

open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http: // which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.

* Address correspondence to this author at the John A. Moran Eye Center, 65 Mario Capecchi Drive, Salt Lake City, Utah 84132, USA; Tel: 801-587-3020; Fax: 801-947-9286; E-mail:


Both choroidal neovascularization during pregnancy, and choroidal neovascularization following implantation of phakic intraocular lenses have been reported in the literature. To our knowledge, this is the first case reported of a gravid woman developing choroidal neovascularization in an eye with a phakic intraocular lens. A 31-year-old woman became aware of her pregnancy three weeks after placement of the Verisyse™ iris-supported phakic intraocular lens. She was at 15 weeks gestation when she developed a Fuch’s spot consistent with choroidal neovascularization. By eight months gestation, her symptoms nearly resolved. While the development of choroidal neovascularization in this patient may appear incidental, women of childbearing age considering phakic intraocular lenses warrant additional discussion on the possible increased likelihood of choroidal neovascularization.

Keywords: Choroidal neovascularization, pregnancy, phakic intraocular lens, antiphospholipid syndrome.